Ronda D. Schaadt - Concepedia

Concepedia

Author

Ronda D. Schaadt

W.E. Upjohn Institute for Employment Research

Also Known As

R D Schaadt, R. D. SCHAADT, R. Schaadt, RONDA D. SCHAADT, Ronda D Schaadt, Ronda D. Schaadt, Ronda Schaadt

21

Publications

1.9K

Citations

14

H-Index

25

Concepts

All Affiliations

W.E. Upjohn Institute for Employment Research

RD

About

Ronda D. Schaadt is an author at W.E. Upjohn Institute for Employment Research specializing in pharmacology, medicine, and antimicrobial resistance.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	640
2	Health Sciences	2	2	267
3	Natural Sciences	1	1	37
4	Biochemistry	1	1	37
5	Biomolecular Engineering	1	1	64

Ronda D. Schaadt

×

14

Publications

1.9K

Citations

14

H-Index

	Year	Citations
Substituent Effects on the Antibacterial Activity of Nitrogen−Carbon-Linked (Azolylphenyl)oxazolidinones with Expanded Activity Against the Fastidious Gram-Negative Organisms <i>Haemophilus </i><i>i</i><i>nfluenzae</i> and <i>Moraxella </i><i>c</i><i>atarrhalis</i> Michaël Génin, Debra A. Allwine, David Anderson, Journal of Medicinal Chemistry	2000	722
In vitro activities of U-100592 and U-100766, novel oxazolidinone antibacterial agents Gary E. Zurenko, Betty H. Yagi, Ronda D. Schaadt, Antimicrobial Agents and Chemotherapy	1996	461
In Vitro Activity of TR-700, the Antibacterial Moiety of the Prodrug TR-701, against Linezolid-Resistant Strains Karen Joy Shaw, Susan M. Poppe, Ronda D. Schaadt, Antimicrobial Agents and Chemotherapy Antimicrobial ChemotherapyVitro SensitivityAntibiotic ResistanceDrug ResistanceMedicinal Chemistry	2008	179
In Vitro Activity of TR-700, the Active Ingredient of the Antibacterial Prodrug TR-701, a Novel Oxazolidinone Antibacterial Agent Ronda D. Schaadt, Debora Sweeney, Dean L. Shinabarger, Antimicrobial Agents and Chemotherapy Vitro PotencyAntimicrobial ChemotherapyMic AssaysMedicinal ChemistryInfection Control	2009	115
Identification of Phenylisoxazolines as Novel and Viable Antibacterial Agents Active against Gram-Positive Pathogens Michael R. Barbachyn, Gary J. Cleek, Lester A. Dolak, Journal of Medicinal Chemistry Bioorganic ChemistryAntibacterial ActivityAntimicrobial ChemotherapyPromising GroupPharmaceutical Chemistry	2002	88
The synthesis and antibacterial activity of 1,3,4-Thiadiazole phenyl oxazolidinone analogues Lisa M. Thomasco, Robert C. Gadwood, Elizabeth A. Weaver, Bioorganic & Medicinal Chemistry Letters Bioorganic ChemistryMedicineAntibacterial ActivityAntibacterial AgentAntimicrobial Chemotherapy	2003	64
U-87947E, a protein quinolone antibacterial agent incorporating a bicyclo[1.1.1]pent-1-yl (BCP) subunit Michael R. Barbachyn, Douglas K. Hutchinson, Dana S. Toops, Bioorganic & Medicinal Chemistry Letters AntibioticsMedicineAntibacterial AgentAntimicrobial ChemotherapyMicrobiology	1993	45
Synthesis and biological evaluation of benzazepine oxazolidinone antibacterials Paul D. Johnson, Paul A. Aristoff, Gary E. Zurenko, Bioorganic & Medicinal Chemistry Letters AntibioticsMedicineAntibacterial AgentAntimicrobial ChemotherapyAntimicrobial Compound	2003	44
New Antibacterial tetrahydro-4(2H)-thiopyran and thiomorpholine S-oxide and S,S-dioxide phenyloxazolidinones Upinder Singh, Belliappa Pemmanda Raju, Stuart Lam, Bioorganic & Medicinal Chemistry Letters Bioorganic ChemistryBiochemistryNatural SciencesS-dioxide PhenyloxazolidinonesAntibacterial Agent	2003	37
Carbon–carbon-linked (pyrazolylphenyl)oxazolidinones with antibacterial activity against multiple drug resistant gram-positive and fastidious gram-negative bacteria Chi‐Sing Lee, Debra A. Allwine, Michael R. Barbachyn, Bioorganic & Medicinal Chemistry Antimicrobial Drug DiscoveryAntibioticsMedicineAntibacterial ActivityMultiple Drug	2001	33

Page 1